NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 806.00
+10.45 (1.31%)
Oct 1, 2025, 3:29 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 144.46 billion as of October 2, 2025. Its market cap has decreased by -49.03% in one year.
Market Cap
144.46B
Enterprise Value
122.34B
Revenue
43.96B
Ranking
n/a
PE Ratio
8.51
Stock Price
806.00
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 144.46B, an increase of 33,543.44%. That is a compound annual growth rate of 24.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2025 | 144.46B | -41.86% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | 175.25B | 62.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,925.79B |
| Divi's Laboratories | 1,515.83B |
| Cipla | 1,222.15B |
| Apollo Hospitals Enterprise | 1,069.90B |
| Mankind Pharma | 1,006.97B |
| Zydus Lifesciences | 997.33B |
| Fortis Healthcare | 747.14B |
| Alkem Laboratories | 652.77B |